Use of calcium channel antagonists in myocardial revascularization procedures

Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1996-06, Vol.77 (16), p.26D-31D
Main Authors: Califf, Robert M., Tardiff, Barbara E., Pieper, Karen S., Hillegass, William B.
Format: Article
Language:English
Subjects:
Angioplasty, Balloon, Coronary
Antianginal agents. Coronary vasodilator agents
Atherectomy
Biological and medical sciences
Calcium
Calcium Channel Blockers - therapeutic use
Cardiovascular disease
Cardiovascular system
Combined Modality Therapy
Coronary Disease - therapy
Drug therapy
Humans
Medical research
Medical sciences
Myocardial Revascularization - methods
Pharmacology. Drug treatments
Randomized Controlled Trials as Topic
Recurrence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c331t-f5881843b32f9403127b81b39354045db25189fefedb0e892e9f7f1a0092fee83
cites cdi_FETCH-LOGICAL-c331t-f5881843b32f9403127b81b39354045db25189fefedb0e892e9f7f1a0092fee83
container_end_page 31D
container_issue 16
container_start_page 26D
container_title The American journal of cardiology
container_volume 77
creator Califf, Robert M.
Tardiff, Barbara E.
Pieper, Karen S.
Hillegass, William B.
description Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the results in CAVEAT with those in published randomized trials. Also reviewed are the use of calcium channel antagonists to control perioperative hypertension, reduce myocardial necrosis, and prevent arrhythmias during cardiopulmonary bypass.
doi_str_mv 10.1016/S0002-9149(96)00305-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78151217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914996003050</els_id><sourcerecordid>78151217</sourcerecordid><originalsourceid>FETCH-LOGICAL-c331t-f5881843b32f9403127b81b39354045db25189fefedb0e892e9f7f1a0092fee83</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhq2Kii7b_gSkqEKIHlI8cZzYJ4QQlEpUPdA9W44zBqPEpnaCBL--3g_toRdOo9E8M_PqIeQY6Heg0JzfU0qrUkItz2TzjVJGeUk_kAWIVpYggR2QxR75RI5SesotAG8OyaFo2lbIekF-rRIWwRZGD8bNY2Eetfc4FNpP-iF4l6ZUOF-Mr8Ho2Ds9FBFfdDLzoKN705MLvniOwWA_R0yfyUerh4RfdnVJVjfXf65uy7vfP35eXd6VhjGYSsuFAFGzjlVW1pRB1XYCOiYZr2nN-67iIKRFi31HUcgKpW0taEplZREFW5LT7d38-u-MaVKjSwaHQXsMc1KtAA4VtBn8-h_4FOboczZVMcqaWmRxS8K3kIkhpYhWPUc36viqgKq1a7VxrdYilWzUxrVa7x3vjs_diP1-ayc3z0928yxMDzZqb1zaYwyaDPGMXWwxzMZeHEaVjEOflbqIZlJ9cO8E-QcqXJo_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230364800</pqid></control><display><type>article</type><title>Use of calcium channel antagonists in myocardial revascularization procedures</title><source>ScienceDirect Journals</source><creator>Califf, Robert M. ; Tardiff, Barbara E. ; Pieper, Karen S. ; Hillegass, William B.</creator><creatorcontrib>Califf, Robert M. ; Tardiff, Barbara E. ; Pieper, Karen S. ; Hillegass, William B.</creatorcontrib><description>Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the results in CAVEAT with those in published randomized trials. Also reviewed are the use of calcium channel antagonists to control perioperative hypertension, reduce myocardial necrosis, and prevent arrhythmias during cardiopulmonary bypass.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(96)00305-0</identifier><identifier>PMID: 8677894</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Angioplasty, Balloon, Coronary ; Antianginal agents. Coronary vasodilator agents ; Atherectomy ; Biological and medical sciences ; Calcium ; Calcium Channel Blockers - therapeutic use ; Cardiovascular disease ; Cardiovascular system ; Combined Modality Therapy ; Coronary Disease - therapy ; Drug therapy ; Humans ; Medical research ; Medical sciences ; Myocardial Revascularization - methods ; Pharmacology. Drug treatments ; Randomized Controlled Trials as Topic ; Recurrence</subject><ispartof>The American journal of cardiology, 1996-06, Vol.77 (16), p.26D-31D</ispartof><rights>1996 Excerpta Medica, Inc.</rights><rights>1996 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Jun 20, 1996</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c331t-f5881843b32f9403127b81b39354045db25189fefedb0e892e9f7f1a0092fee83</citedby><cites>FETCH-LOGICAL-c331t-f5881843b32f9403127b81b39354045db25189fefedb0e892e9f7f1a0092fee83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3169435$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8677894$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Califf, Robert M.</creatorcontrib><creatorcontrib>Tardiff, Barbara E.</creatorcontrib><creatorcontrib>Pieper, Karen S.</creatorcontrib><creatorcontrib>Hillegass, William B.</creatorcontrib><title>Use of calcium channel antagonists in myocardial revascularization procedures</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the results in CAVEAT with those in published randomized trials. Also reviewed are the use of calcium channel antagonists to control perioperative hypertension, reduce myocardial necrosis, and prevent arrhythmias during cardiopulmonary bypass.</description><subject>Angioplasty, Balloon, Coronary</subject><subject>Antianginal agents. Coronary vasodilator agents</subject><subject>Atherectomy</subject><subject>Biological and medical sciences</subject><subject>Calcium</subject><subject>Calcium Channel Blockers - therapeutic use</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular system</subject><subject>Combined Modality Therapy</subject><subject>Coronary Disease - therapy</subject><subject>Drug therapy</subject><subject>Humans</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Myocardial Revascularization - methods</subject><subject>Pharmacology. Drug treatments</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Recurrence</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkE1P3DAQhq2Kii7b_gSkqEKIHlI8cZzYJ4QQlEpUPdA9W44zBqPEpnaCBL--3g_toRdOo9E8M_PqIeQY6Heg0JzfU0qrUkItz2TzjVJGeUk_kAWIVpYggR2QxR75RI5SesotAG8OyaFo2lbIekF-rRIWwRZGD8bNY2Eetfc4FNpP-iF4l6ZUOF-Mr8Ho2Ds9FBFfdDLzoKN705MLvniOwWA_R0yfyUerh4RfdnVJVjfXf65uy7vfP35eXd6VhjGYSsuFAFGzjlVW1pRB1XYCOiYZr2nN-67iIKRFi31HUcgKpW0taEplZREFW5LT7d38-u-MaVKjSwaHQXsMc1KtAA4VtBn8-h_4FOboczZVMcqaWmRxS8K3kIkhpYhWPUc36viqgKq1a7VxrdYilWzUxrVa7x3vjs_diP1-ayc3z0928yxMDzZqb1zaYwyaDPGMXWwxzMZeHEaVjEOflbqIZlJ9cO8E-QcqXJo_</recordid><startdate>19960620</startdate><enddate>19960620</enddate><creator>Califf, Robert M.</creator><creator>Tardiff, Barbara E.</creator><creator>Pieper, Karen S.</creator><creator>Hillegass, William B.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19960620</creationdate><title>Use of calcium channel antagonists in myocardial revascularization procedures</title><author>Califf, Robert M. ; Tardiff, Barbara E. ; Pieper, Karen S. ; Hillegass, William B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c331t-f5881843b32f9403127b81b39354045db25189fefedb0e892e9f7f1a0092fee83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Angioplasty, Balloon, Coronary</topic><topic>Antianginal agents. Coronary vasodilator agents</topic><topic>Atherectomy</topic><topic>Biological and medical sciences</topic><topic>Calcium</topic><topic>Calcium Channel Blockers - therapeutic use</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular system</topic><topic>Combined Modality Therapy</topic><topic>Coronary Disease - therapy</topic><topic>Drug therapy</topic><topic>Humans</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Myocardial Revascularization - methods</topic><topic>Pharmacology. Drug treatments</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Recurrence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Califf, Robert M.</creatorcontrib><creatorcontrib>Tardiff, Barbara E.</creatorcontrib><creatorcontrib>Pieper, Karen S.</creatorcontrib><creatorcontrib>Hillegass, William B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Califf, Robert M.</au><au>Tardiff, Barbara E.</au><au>Pieper, Karen S.</au><au>Hillegass, William B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of calcium channel antagonists in myocardial revascularization procedures</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>1996-06-20</date><risdate>1996</risdate><volume>77</volume><issue>16</issue><spage>26D</spage><epage>31D</epage><pages>26D-31D</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Calcium channel antagonists possess a number of properties that may be beneficial after revascularization procedures. Therefore, we present an overview of the use of these drugs after percutaneous intervention in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT), and compare the results in CAVEAT with those in published randomized trials. Also reviewed are the use of calcium channel antagonists to control perioperative hypertension, reduce myocardial necrosis, and prevent arrhythmias during cardiopulmonary bypass.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8677894</pmid><doi>10.1016/S0002-9149(96)00305-0</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 1996-06, Vol.77 (16), p.26D-31D
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_78151217
source ScienceDirect Journals
subjects Angioplasty, Balloon, Coronary
Antianginal agents. Coronary vasodilator agents
Atherectomy
Biological and medical sciences
Calcium
Calcium Channel Blockers - therapeutic use
Cardiovascular disease
Cardiovascular system
Combined Modality Therapy
Coronary Disease - therapy
Drug therapy
Humans
Medical research
Medical sciences
Myocardial Revascularization - methods
Pharmacology. Drug treatments
Randomized Controlled Trials as Topic
Recurrence
title Use of calcium channel antagonists in myocardial revascularization procedures
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A58%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20calcium%20channel%20antagonists%20in%20myocardial%20revascularization%20procedures&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Califf,%20Robert%20M.&rft.date=1996-06-20&rft.volume=77&rft.issue=16&rft.spage=26D&rft.epage=31D&rft.pages=26D-31D&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(96)00305-0&rft_dat=%3Cproquest_cross%3E78151217%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c331t-f5881843b32f9403127b81b39354045db25189fefedb0e892e9f7f1a0092fee83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230364800&rft_id=info:pmid/8677894&rfr_iscdi=true